Sangamo BioSciences | SGMO - Market Capitalization


Sangamo BioSciences reported $79.1M in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Alaunos Therapeutics USD 5M 2M Sep/2025
Alnylam Pharmaceuticals USD 59.77B 17.25B Sep/2025
Alterity Therapeutics Limited AUD 11M 5M Jun/2023
Amgen USD 201.45B 25.2B Feb/2026
Bayer EUR 27.23B 2.14B Sep/2025
BioCryst Pharmaceuticals USD 1.23B 115M Dec/2023
Biogen USD 27.01B 1.19B Feb/2026
BioMarin Pharmaceutical USD 10.4B 142M Sep/2025
Cipla INR 1.22T 6.47B Dec/2025
Clal Biotechnology ILS 47.99M 4.37M Jan/2026
Compugen USD 137.5M 21.89M Sep/2025
CSL USD 76.3B 60.04B Jun/2025
Gilead Sciences USD 183.59B 31.31B Feb/2026
GlaxoSmithKline GBP 87.33B 12.98B Feb/2026
Grifols EUR 6.77B 773M Sep/2025
Ionis Pharmaceuticals USD 10.43B 4.14B Sep/2025
J&J USD 500.24B 67.44B Dec/2025
Merck USD 300.37B 39.11B Feb/2026
Novartis USD 265.66B 9.48B Sep/2025
Omeros USD 184M 158M Sep/2023
Pfizer USD 152.89B 11.32B Feb/2026
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 100.88B 4.46B Dec/2025
Sarepta Therapeutics USD 2.02B 336M Sep/2025
Tectonic Therapeutic USD 294M 77M Sep/2025
Ultragenyx Pharmaceutical USD 2.9B 539M Sep/2025
Vertex Pharmaceuticals USD 100.41B 13.91B Sep/2025